This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cade, J. F. Articles by Rennie, G. C. Search for Related Content PubMed PubMed Citation Articles by Cade, J. F. Articles by Rennie, G. C.

Circulation, Vol 66, 29-32, Copyright © 1982 by American Heart Association

ARTICLES

Platelet function in coronary artery disease: effects of coronary surgery and sulfinpyrazone

JF Cade, DJ Doyle, CN Chesterman, FJ Morgan and GC Rennie

Platelet survival and plasma concentrations of beta thromboglobulin and platelet factor 4 were measured in 44 patients before and 6 months after coronary artery bypass grafting. Postoperatively, patients were randomized to receive sulfinpyrazone, 800 mg/day, or placebo. Preoperatively, platelet survival was significantly shorter than normal, and plasma concentrations of both platelet-specific proteins were significantly elevated. Postoperatively, all three indexes of platelet function tended to become normal, but these changes were statistically significant only in patients treated with sulfinpyrazone. Postoperative exercise testing correlated significantly with plasma concentrations of beta thromboglobulin and platelet factor 4 measured preoperative and postoperative. These results are consistent with reports of the effects of sulfinpyrazine on platelet involvement in other conditions, and suggest that the drug reduces platelet activation and inhibits actual destruction. The results also show a relationship between abnormalities of platelet function and an index of postoperative myocardial ischemia.

This article has been cited by other articles:

				D. Lamarche, R. Taddeo, and C. Pepler The Preparation of Patients for Cardiac Surgery Clin Nurs Res, November 1, 1998; 7(4): 390 - 405. [Abstract] [PDF]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				J. L. Franklin, J. Simmons, B. Solovitz, J. R. Clemons, and G. E. Miller Assessing Quality of Life of the Mentally Ill: A Three-Dimensional Model Eval Health Prof, September 1, 1986; 9(3): 376 - 388. [Abstract] [PDF]